Skip to main content

Table 1 Overview of endpoints, time of data collection for the BRE-4-MED registry concept

From: Development and proof-of-concept of a multicenter, patient-centered cancer registry for breast cancer patients with metastatic disease—the “Breast cancer care for patients with metastatic disease” (BRE-4-MED) registry

Observation

Screening

enrolment/baseline

3 months

6 months

12 months

18 months (study termination)

APP (Fort-nightly)

Cancer registry data

Occurrence of event

Timeframe

 

+ 1 day

+/− 2 weeks

+/− 2 weeks

+/− 2 weeks

+/− 2 weeks

+/− 3 days

+/− 1 month

 

Eligibility check

       

Patient information

        

Informed consent

 

       

Endpoints:

         

(a) Treatment:

 Physicians questionnaire

 

     

(b) Patient and caregiver:

 Quality of life/health status1

 

  

 Physical functioning2

 

  

 Depression/anxiety3

 

   

 Caregiver burden4

  

   

 Individual patient’s needs5

 

  

 Access to health care services6

 

  

 Physician’s empathy7

 

   

 Vital status, therapy change, progression

 

  

 Socio-demographics

 

   

(3) Treatment framework:

 Living area

 

       

 Health care settings

 

      

Core Data

     

 

Confounders

 

     

Endpoints

 

   
  1. 1EORTC-QLQ-2 (Version 3); 2PROMs (PROMIS, physical function) 4-item scale; 3depression and anxiety (Patient Health Questionnaire-4 (PHQ-4)); 4caregiver burden (Caregiver Reaction Assessment (CRA)); 5patient’s health care needs (i.e., social, informational, psycho-oncological, administrative support); 6access to health care services (i.e., psycho-oncological therapy, self-aid group, medical rehabilitation, palliative care, sports); 7consultation and relational empathy (CARE)